Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells

Cell Biochemistry and Function

Volumn 26, Issue 5, 2008, Pages 548-556

  Zheng, Rong ^a   Xiong, Qi ^a   Zuo, Bo ^a   Jiang, SiWen ^a   Li, FengE ^a   Lei, MingGang ^a   Deng, ChangYan ^a   Xiong, YuanZhu ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

RNAi; Signal transduction; Smad2; Smad3; Transforming growth factor (TGF )

Indexed keywords

MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE FUNCTION; GENE VECTOR; GENETIC TRANSFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; FIBROBLASTS; HUMANS; MICE; NIH 3T3 CELLS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

MAMMALIA;

EID: 48249144846     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1464     Document Type: Article

References (39)

1. Massague J, Chen YG. Controlling TGF-β signaling. Genes Dev. 2000; 14: 627-644.
2. Whitman M. Smads and early developmental signaling by the TGFβ superfamily. Genes Dev. 1998; 12: 2445-2462.
3. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF β-inducible element in the promoter of human plasminogen activator inhibitor-type1 gene. EMBO J 1998; 17: 3091-3100.
4. Massuge J, Wotton D. Transcriptional control by the TGF-β/ Smad signaling system. EMBO J 2000; 19: 1745-1754.
5. Zhu Q, Person-White S, Luo K. Requirement for SnoN oncoprotein in transforming growth factor β-induced oncogenic transformation of fibroblast cells. Mol Cell Biol 2005; 24: 10731-10744.
6. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF. Targeted disruption of Smad3 reveals an essential role in transforming growth factor-β -mediated signal transduction. Mol Cell Biol 1999; 19: 2495-2504.
7. Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 1999; 18: 1280-1291.
8. Weinstein M, Yang X, Li C, Xu X, Gotay J, Deng CX. Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc Natl Acad Sci USA 1998; 95: 9378-9383.
9. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998; 393: 786-790.
10. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
11. Cogoni C, Macino G. Post-transcriptional gene silencing across kingdoms. Curr Opin Genet Dev 2000; 10: 638-694.
12. Plasterk RH, Retting RF. The silencing of the gene. Curr Opin Genet Dev 2000; 10: 562-567.
13. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in mammalian cell culture. Nature 2001; 411: 494-498.
14. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Cell 2002; 296: 550-553.
15. Xia H, Mao Q, Paulson HL, Davidson Bl. SiRNA-mediated gene silencing in vitro and vivo. Nat Biotechnol 2002; 20: 1006-1010.
16. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cell. Proc Natl Acad Sci USA 2002; 99: 1443-1448.
17. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326-330.
18. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-366.
19. Hannon GJ. RNA interference. Nature 2002; 418: 244-251.
20. Kobayashi N, Matsui Y, Kawase A, et al. Vector-based in vivo RNA interfence: dose- and time- dependent suppression of transgene expression. J Pharmacol Exp Ther 2004; 308: 688-693.
21. Yu JY, DeRuiter SL, Turner DL. RNA interfence by expression of short- interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 6047-6052.
22. Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA 2002; 8: 855-860.
23. McManus MT, Haines BB, Dillon CP, et al. Small interfering RNA-mediated gene sileneing in T-lymphocytes. J Immunol 2002; 169: 5754-5760.
24. Sui GC, Soohoo C, Affar el B, et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci USA 2002; 99: 5515-5520.
25. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammlian cells using small interfering RNAs. Methods 2002; 26: 199-213.
26. Khvorova A, Reynolds A, Jayasena SD. Functional siRNAs and miRNA exhibit strand bias. Cell 2003; 115: 209-216.
27. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21- and 22- nucleotide RNAs. Genes Dev 2001; 15: 188-200.
28. Yamamura Y, Hua X, Bergelson S, Lodish HF. Critical role of Smads and AP-1 complex in transforming growth factorbeta-dependent apoptosis. J Biol Chem 2000; 275: 36295-36302.
29. Dennler S, Huet S, Gauthier JM. A short amino-acid sequence in MH1domain is responsible for functional differences between Smad2 and Smad3. Oncogene 1999; 18: 1643-1648.
30. Piek E, Ju WJ, Heyer J, et al. Functional characterization of transforming growth factor signaling in Smad2-and Smad3-deficient fibroblasts. J Biol Cell 2001; 276: 19945-19953.
31. Li YJ, Azuma A, Usuki J, et al. EM703 improves bleomycin-induces pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts. Respir Res 2006; 7: 16.
32. Zhao Y, Geverd DA. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-β singnaling. Biochem Biophys Res Commun 2002; 294: 319-323.
33. Kim SG, Kim HA, Jong HS, et al. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 2005; 16: 4672-4683.
34. Inman GJ, Nicolás FJ, Hill CS. Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-β receptor activity. Mol Cell 2002; 10: 283-294.
35. Moren A, Itoh S, Moustakas A, ten Dijke P, Heldin C-H. Functional consequences of tumorigenic missense mutations in the aminoterminal domain of Smad4. Oncogene 2000; 19: 4396-4404.
36. Chacko BM, Qin B, Correia JJ, Lam SS, de Caestecker MP, Lin K. The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat Struct Biol 2001; 8: 248-253.
37. Wu JW, Fairman R, Penry J, Shi Y. Formation of a stable heterodimer between Smad2 and Smad4. J Biol Chem 2001; 276: 20688-20694.
38. Liu F, Pouponnot C, Massague J. Dual role of the Smad4/DPC4 tumor suppressor in TGF inducible transcriptional complexes. Genes Dev 1997; 11: 3157-3167.
39. Sirard C, Kim S, Mirtsos C, et al. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor betarelated signaling. J Biol Chem 2000; 21: 2063-2070.